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Abstract
Flotillin-1 and flotillin-2 are important regulators of signal transduction pathways such as growth factor signaling. Flotillin
expression is increased under pathological conditions such as neurodegenerative disorders and cancer. Despite their
importance for signal transduction, very little is known about the transcriptional regulation of flotillins. Here, we analyzed
the expression of flotillins at transcriptional level and identified flotillins as downstream targets of the mitogen activated
kinases ERK1/2. The promoter activity of flotillins was increased upon growth factor stimulation in a MAPK dependent
manner. Overexpression of serum response factor or early growth response gene 1 resulted in increased flotillin mRNA and
protein expression. Furthermore, both promoter activity and expression of endogenous flotillins were increased upon
treatment with retinoic acid or by overexpression of the retinoid X receptor and its binding partners RARa and PPARc. Our
data indicate that the expression of flotillins, which can be detected in all cultured cells, is fine-tuned in response to various
external stimuli. This regulation may be critical for the outcome of signaling cascades in which flotillins are known to be
involved.
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Introduction
The family of flotillin proteins consists of two homologous
members, flotillin-1 and flotillin-2, also termed ‘‘reggies’’, with
flotillin-1 being identical to reggie-2 and flotillin-2 to reggie-1
[1,2]. Flotillins are highly conserved among species and show a
wide expression pattern in various cell and tissue types (see
overview in [3]). Flotillins are constitutively associated with certain
types of membrane microdomains known as ‘‘lipid rafts’’ by means
of acylation [4,5] and oligomerization [6,7], and they do not
traverse the membrane but reside on the cytoplasmic side of it.
One major function of lipid rafts is to organize signaling
partners into functional complexes [8]. Within rafts, flotillins have
been suggested to provide platforms for the assembly of signaling
molecules and thus function as regulators of several signal
transduction pathways associated with membrane receptors, e.g.
insulin [9], IgE receptor [10], IL-6/STAT3 signaling [11], G
protein coupled receptor [12] and of the neurotrophin receptor
TrkA. Furthermore, we have recently shown that flotillin-1 is
crucial for receptor tyrosine kinase signaling through the
epidermal growth factor (EGF) [13] and fibroblast growth factor
(FGF) receptors [14] and thereby regulates the MAP kinase
signaling [13]. In the case of all signal transduction pathways in
which flotillins are known to be involved, the absence of flotillins
leads to a severe impairment of the signaling cascade [10–13].
During EGF receptor (EGFR) signaling, the absence of flotillin-1
results in reduced phosphorylation of specific tyrosines in the
EGFR and in inefficient activation of the downstream mitogen
activated protein (MAP) kinase and Akt signaling [13]. The
cellular activation ERK1/2 is preceded by the activation of
receptor tyrosine kinases (e.g. EGFR) by growth factors, which is
followed by the binding of the SH2 domain-containing adaptor
protein Grb2 in association with the guanine exchange factor
SOS, activation of Ras and subsequently of the serine-threonine
kinase Raf. Active Raf kinase phosphorylates MEK1/2 which in
turn phosphorylate ERK1/2 on both tyrosine and threonine
residues.
Despite their almost ubiquitous expression, information on the
regulation of flotillin expression is scarce. At protein level, flotillins
stabilize each other, and siRNA-mediated knockdown of flotillin-2
severely reduces the expression of flotillin-1, while the mRNA level
is not affected ([7] and our own unpublished data). In HeLa cells,
flotillin-1 depletion results in about 50% loss of flotillin-2, again
without effect on the mRNA level [13]. Heterooligomerization
with flotillin-2 appears to be an important factor for stabilizing
flotillin-1 and enabling the endocytosis of flotillins after growth
factor stimulation [6].
Flotillin expression is altered under some pathological condi-
tions. In 60% of human breast cancer samples, flotillin-1 was
found to be overexpressed, which correlates with a poor patient
survival [15], and in renal cell carcinomas [16]. Similarly, flotillin-
2 is upregulated in melanoma [17,18] and in metastatic
nasopharyngeal carcinoma cells [19]. Moreover, flotillin expres-
sion is increased in neurodegenerative diseases such as Alzheimer’s
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disease [20–22], and Parkinson’s disease [23], as well as in severe
acute respiratory syndrome (SARS) [24]. Overexpression of
flotillin-2 in non-tumorigenic melanoma cells results in melanoma
progression and formation of metastases [18].
Because of their ability to modulate the outcome of signaling
cascades and to stimulate cell proliferation [15,18,25], cell
spreading [26] and filopodia formation [4,27], which are processes
important during carcinogenesis and metastasis formation, the
correct cellular amount of flotillins is crucial for the ability of a cell
to react on certain external stimuli (e.g. growth factors) and to
maintain a balance between cell proliferation and cell death. Thus,
the regulation of the expression of flotillins in order to allow for the
cells to adapt to environmental clues is of major importance.
Nevertheless, very little information is available on factors that
regulate flotillins at transcriptional level. Flotillin-2 was described
to be a target gene of the p53 transcription factor family members
p63 and p73, but not of p53 itself [11]. Lopez-Casas et al. [28]
showed that flotillin-1 mRNA is upregulated upon increasing cell
density in 3T3 fibroblasts. They isolated a fragment of the
promoter of murine flotillin-1 and identified putative binding sites
for Sp1, AmL-1a, MZF1, c-Ets1, and Lyf-1 in the genomic
sequence within about 500 bp upstream of the transcription start
site. Unfortunately, the functional role of none of these transcrip-
tion factors in the regulation of flotillin-1 transcription was
analyzed further. In microarray experiments, both flotillin-1 and
flotillin-2 were found to be upregulated upon stimulation of
myeloid progenitor cells with granulocyte colony-stimulating
factor (G-CSF), a cytokine that leads to differentiation of
progenitor cells into neutrophilic granulocytes in a STAT3-
dependent process [29]. In drosophila, flotillin-2 has recently been
shown to be transcriptionally regulated upon embryonic wound
response [30].
In order to characterize the signals that modulate the expression
level of flotillins, we have here analyzed the proximal promoter
regions of human and murine flotillins. We here show that the
transcription factors Egr1, SRF, RXRa, RARa, and PPARc are
positive regulators of flotillin-1 and flotillin-2 expression and that
several stimuli that activate the MAP kinase pathway result in
increased expression of flotillins.
Materials and Methods
Ethics statement
Ethical approval was not required for this study because under
the German Animal Welfare Act, any procedure that involves the
euthanasia of the animal and post-mortem retrieval of organs
(including the uterus with the embryos) is not subject to a special
ethical approval. All procedures used in this study involving
embryonic fibroblast isolation have been declared to the local
authorities of Regierungspra¨sidium Giessen (Regional Council of
Giessen) (registry number V54-19c20/15cGI20/2). The mice used
for the MEF isolation were treated in accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and of
local authorities. All animals were sacrificed after proper
anesthesia to ensure minimal suffering.
Cell culture
HeLa cells (human cervix carcinoma, obtained through
American Type Culture Collection), and primary murine embry-
onic fibroblasts (MEF) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Gibco, Invitrogen, Karlsruhe, Ger-
many), high glucose, supplemented with 10% fetal calf serum
(FCS, Gibco), 100 U/ml Penicillin and 100 mg/ml Streptomycin
(Sigma-Aldrich, Taufkirchen, Germany) at 8% CO2 and 37uC.
Cell culture medium for MEFs was additionally supplemented
with 1% non-essential amino acids and 1 mM sodium pyruvate.
MEFs were isolated from day E13.5 mouse embryos (strain
C57BL6/J) using standard protocols (see http://www.molgen.
mpg.de/,rodent/MEF_protocol.pdf).
Plasmids and mutagenesis
Genomic fragments directly upstream of the ATG start codon
of human and murine flotillin-1 and flotillin-2 promoters were
amplified by PCR from genomic DNA of HeLa and MEF cells,
respectively, and cloned into the pDrive cloning vector (PCR
cloning kit, Qiagen, Hilden Germany). The resulting constructs
served as templates for the PCR amplification of shortened
promoter fragments which were subcloned into pGL3-basic
(Promega, Mannheim, Germany) using KpnI and HindIII or
HindIII digestions. In the case of the flotillin-1 gene, the start
codon is in the second exon, while it is in the first exon of the
flotillin-2 gene. For each human flotillin gene, four promoter
constructs with a length of 2600, 1330, 630, and 375 bp (flotillin-1)
and 2130, 1385, 930, and 560 bp (flotillin-2) were generated.
In the human genomic sequence, the flotillin-1 gene resides in
the immediate vicinity of the putative gene immediate early
response gene 3 (IER3). Thus, the longest flotillin-1 promoter
construct F1-2660 also contains the complete sequence of IER3,
while the shorter constructs either started in the 39UTR region of
IER3 (F1-1330), in the 567 bp intergenic sequence between IER3
and flotillin-1 (F1-630), or in the first exon of flotillin-1 (F1-375).
The murine flotillin-1 promoter construct starts in the 39UTR of
IER3.
Similarly, the human flotillin-2 gene is flanked by a gene for the
dehydrogenase/reductase family member 13 (DHRS13). The two
longest flotillin-2 promoter constructs F2-2130 and F2-1385
contain parts of the coding region of DHRS13, while the two
shorter constructs F2-930 and F2-560 start in the 39UTR of
DHRS13. The murine flotillin-2 promoter construct starts in the
last exon of the putative DHRS13 gene.
Mutagenesis of the RXR binding sites in the mouse flotillin-2
promoter were performed by means of overlap extension PCR
[31] using the primers shown in Table 1. Egr1 binding sites were
deleted by PCR. We generated constructs containing mutations of
one of the three RXR binding sites or mutations combined with a
deletion in the 39 region that removes the Egr1 binding sites.
Correctness of all constructs generated for this study was verified
by sequencing.
Expression plasmids for RARa (#16287), RXRa (#8882), Egr1
(#11729), SRF (#11977), and PPARc (#8895) were obtained
from Addgene. (Numbers in parentheses refer to the respective
plasmid numbers of Addgene). As an empty vector control, PSV-
Sport (Invitrogen) was used, whereas pRL-TK (Promega, Mann-
heim, Germany) was utilized for the normalization of firefly
luciferase activity. The expression constructs for ERK2 were
obtained from N. Ahn (Univ. of Colorado, USA) and were as
described [32]. All plasmids and primers are listed in Table 1.
Computer-based sequence analysis
Analysis of the flotillin-1 and flotillin-2 promoter regions of homo
sapiens, mus musculus, rattus norvegicus, pan troglodytes and bos taurus for
putative transcription factor binding sites common to all five
species was performed using the MatInspector program. Multiple
sequence alignments were done with DiAlign professional TF
(Genomatix Software GmbH, Munich) [33].
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Transfection and reporter gene assays
24 h prior to transfection, cells were seeded to 24-well plates.
For transfections, 15 ng of pRL-TK and either 150 ng promoter
construct alone or 100 ng promoter construct and 100 ng
expression plasmid were transfected using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol. After 6 h,
Table 1. Oligonucleotides and plasmids.
Oligonucleotide or plasmid
Sequence (59R39)a or description
(Restriction sites are underlined)
Accession no. or
reference
Oligos
Flot1-2660 fwd GAGGTACCCTGTGGCTAAAGTGAGCCCCTC (KpnI)
Flot1-1330 fwd ACCTGAAGCTTCGGCAAAGTAGGAG (HindIII)
Flot1-630 fwd CCAGGTACCCCGGCTGGGCCCGAGAGCCAG (KpnI)
Flot1-375 fwd CCGAGAAGCTTGCCGGGCTGCCGCC (HindIII)
Flot1 rev AAAAGCTTGTTCAGGCTGGAGCTGGAGGAG (HindIII)
Flot2-2130 fwd CAGAGGTACCTGGTGTGCTTGAGAAAGGCT (KpnI)
Flot2-1385 fwd TAGCTAAGCTTGTAAATACACACCA (HindIII)
Flot2-930 fwd TCTAAGAAGCTTCACCGAATTCAGG (HindIII)
Flot2-560 fwd AGAGGTACCGAGTTTGCAATGTGATGCACT (KpnI)
Flot2 rev TTAAGCTTGGCGCCGGCGGCACGGAGGGCC (HindIII)
Flot2 ChIP fwd GAGCTAAGGGACTCGCCTAG
Flot2 ChIP rev CTCGGGACCGCACAGACCCG
Flot1 mouse fwd GCTTCTCAGGGGCAGCTGCA
Flot1 mouse rev CACAAGTGAAAAGCTTGGTTGAAGC
Flot2 mouse fwd GCATTGAGCCCCTCAGCGGGA
Flot2 mouse rev TGGCAGTTAAGCTTGGCGCCGTTGGCA
mFlot2-dEgr1 CTATA AAGCTT GCCCCGCCGGAAGTGTAGCG
RXR1-mut-fwd GCTAGAGATGACCAGGCTGCTCAATAATAATGGAAAGCTACCAAGAAGTTGG
RXR1-mut-rev CCAACTTCTTGGTAGCTTTCCATTATTATTGAGCAGCCTGGTCATCTCTAGC
RXR2-mut-fwd GAACCTACACCCTAACTTTCCTTTAACCCGGGATAGAATGC
RXR2-mut-rev GCATTCTATCCCGGGTTAAAGGAAAGTTAGGGTGTAGGTTC
RXR3-mut-fwd GGGTTGCCACATTTACCTCGG TTAA TCTTGTCATGTCCTGAACAGCCC
RXR3-mut-rev GGGCTGTTCAGGACATGACAAGATTAACCGAGGTAAATGTGGCAACCC
qPCR-Rpl13a fwd CCTGGAGGAGAAGAGGAAAGAGA NM_012423.2
qPCR-Rpl13a rev TTGAGGACCTCTGTGTATTTGTCAA NM_012423.2
GAPDH fwd CATCTTCCAGGAGCGAGATCCC NM_002046.3
GAPDH rev CCAGCCTTCTCCATGGTGGT NM_002046.3
qPCR-Flot1 fwd TATGCAGGCGGAGGCAGAAG NM_005803.2
qPCR-Flot1 rev CAGTGTGATCTTATTGGCTGAA NM_005803.2
qPCR-Flot2 fwd GAGATTGAGATTGAGGTTGTG NM_004475.2
qPCR-Flot2 rev ATCCCCGTATTTCTGGTAGG NM_004475.2
Plasmids
pGL3-basic Firefly luciferase reporter gene plasmid without any promoter Qiagen
pRL-TK Renilla luciferase reporter gene plasmid for normalization Promega
pCIG-VP16 RARa RARa expression plasmid Addgene 16287, [81]
pSV Sport RXRa RXRa expression plasmid Addgene 8882, [82]
pcDNA3-Egr1 Egr-1 expression plasmid Addgene 11729, [36]
pCGN-SRF SRF expression plasmid Addgene 11977, [83]
pSV Sport PPARc PPARc expression plasmid Addgene 8886, [82]
pSV Sport Control expression plasmid Invitrogen
WT-ERK2 Wild-type rat ERK2 [32], N. Ahn
CA-ERK2 Constitutively active ERK2 (Leu72Pro+Ser151Asp) [32], N. Ahn
DN-ERK2 Dominant negative ERK2 (Lys52Arg) [32], N. Ahn
doi:10.1371/journal.pone.0045514.t001
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the medium was exchanged into serum-free medium. Treatment
with hEGF (10 ng/ml), trans-retinoic acid (1 mM), phorbol
myristate acetate (PMA, 10 ng/ml), MEK1/2 inhibitor U0126
(10 mM; Cell Signaling, Frankfurt, Germany), bFGF (10 ng/ml,
Peprotech, Germany), FCS (10%), or troglitazone (1–10 mM,
Sigma-Aldrich) in serum-free medium was started 24 h after
transfection and continued for 24 h. In experiments without
stimulation, cells were harvested 48 h after transfection. Cells were
lysed in passive lysis buffer (Promega). Determination of firefly and
renilla luciferase activity was performed with a Tecan infinite
M200 plate reader, using 20 ml of lysate and 85 ml of beetle or
renilla juice reagent (PJK, Kleinblittersdorf, Germany). Relative
luciferase activity was calculated by dividing firefly luciferase
activity by renilla luciferase activity.
Antibodies
Rabbit polyclonal antibodies against RARa (sc-551) and RXRa
(sc-774) were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Rabbit monoclonal anti-Egr1 antibody was from
Cell Signaling. A mouse monoclonal antibody against GAPDH
was obtained from Biozol (Eching, Germany). For detection of
flotillin-1 and flotillin-2 in Western blots, monoclonal antibodies
from Transduction Laboratories (Franklin Lakes, NJ, USA) were
used. Secondary antibodies goat anti-mouse and goat anti-rabbit
coupled to horseradish peroxidase (HRP) were obtained from
Southern Biotechnologies (Birmingham, AL, USA) and Zymed
(Invitrogen, Karlsruhe, Germany), respectively.
Western blotting analysis
The same lysates that were used for determining the activity
of firefly and renilla luciferases were used for Western blot
Figure 1. Basal activity of flotillin-1 (A) and flotillin-2 (B) promoter deletion constructs. Flotillin promoter fragments of different length
were cloned into pGL3-basic vector and transiently transfected into Hela cells. The cells were lysed 48 h post-transfection. Relative luciferase activity
of the longest promoter construct was set as 1. Values are means 6 standard deviation of at least 4 experiments, each measured in duplicates. ***
p,0.001; **p,0.01; *p,0.05 vs. the longest construct.
doi:10.1371/journal.pone.0045514.g001
Table 2. Pairwise similarities of promoter regions (shown as % identical nucleotides).
Flotillin-1 Flotillin-2
Mus
Musculus
Rattus
Norvegicus Pan Troglodytes
Bos
Taurus
Mus
Musculus
Rattus
Norvegicus Pan Troglodytes Bos Taurus
Homo Sapiens 51% 55% 98% 57% 58% 64% 98% 57%
Mus Musculus 83% 47% 37% 85% 55% 42%
Rattus Norvegicus 50% 39% 57% 36%
Pan Troglodytes 56% 57%
doi:10.1371/journal.pone.0045514.t002
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analysis. Protein concentrations were determined according to
Bradford using the BioRad Protein Assay reagent (BioRad,
Munich, Germany). Equal protein amounts were analyzed by
10% SDS-polyacrylamide gel electrophoresis and Western blot.
For antibody staining, the membranes were blocked with 5%
non-fat dry milk in TBST (10 mM Tris, 150 mM NaCl, 0.05%
Tween 20) and incubated overnight at 4uC with the indicated
primary antibodies diluted in 2.5% non-fat dry milk in TBST.
This was followed by incubation with HRP-conjugated
secondary antibodies in TBST for 1 h at room temperature
before development with the AmershamTM ECLTM Western
Blotting Detection Reagents (GE Healthcare, Buckingham-
shire, UK).
RNA isolation and qPCR
Total RNA was isolated using peqGold Trifast reagent (Peqlab,
Erlangen, Germany). RNA (3 mg) was reverse transcribed with
150 fmol oligo(dT)15 primers and 180 U Moloney murine
leukemia virus reverse transcriptase (Promega) in a total volume
of 45 ml. Real time PCRs (ABI7300, Applied Biosystems,
Darmstadt, Germany) were performed in triplicates with 1 ml of
5-fold diluted cDNA in 25 ml reaction mixtures using Absolute
QPCR Sybr Green Mix (Thermo Fisher Scientific, Bonn,
Germany). The annealing temperature was 60uC for all PCR
reactions. Primers were designed to be specific for the cDNA with
PerlPrimer. Primer sequences are listed in Table 1. PCR products
were quantified with the DCt-method. The mean of the reference
genes Rpl13a and GAPDH was used for normalization.
Figure 2. Flotillin promoter activity is induced by EGF, PMA, FGF and FCS. Flotillin promoter fragments of different length were transiently
transfected into Hela cells. One day post transfection, the cells were stimulated with EGF (10 ng/ml), U0126 (10 mM) (A), PMA (10 ng/ml) (B), FGF
(10 ng/ml) (C), or FCS (10%) (D) for 24 h in serum-free medium. Relative luciferase activity of the unstimulated longest promoter construct was set as
1. Values are means6 standard deviation of at least 3 experiments measured in duplicates. *** p,0.001; **p,0.01; *p,0.05 vs. unstimulated sample.
doi:10.1371/journal.pone.0045514.g002
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Chromatin Immunoprecipitation (ChIP)
ChIP was performed as described [34] with slight modifications.
In short, per experiment, one confluent 15 cm dish of HeLa cells
was fixed in 1% formaldehyde at 37uC for 10 min. Cross-linking
was stopped by addition of 125 mM glycine in PBS for 10 min at
room temperature. Cells were washed with PBS and harvested by
scraping. After centrifugation (5 min, 380 g, 4uC) the cell pellet
was resuspended in 1,5 ml of cold lysis buffer A (10 mM HEPES,
10 mM KCl, 1.5 mM MgCl2, 0.1 mM EDTA, 0.35 M sucrose,
pH 7.9) supplemented with protease inhibitor cocktail (Sigma-
Aldrich) and incubated on ice for 10 min. Thereafter, the lysates
were centrifugated for 15 min, 4000 g, 4uC. The obtained pellet
containing the nuclei was resuspended in 1 ml cold lysis buffer B
(20 mM HEPES, 420 mM NaCl, 1.5 mM MgCl2, 0.1 mM
EDTA, 10% glycerol, pH 7.9) supplemented with protease
inhibitor cocktail. The chromatin was fragmented to an average
length of 200–1000 bp by sonicating 10620 s, 25% amplitude
(UW mini20, Bandelin electronic, Berlin, Germany). After
centrifugation (20 min, 16000 g, 4uC), a 100 ml aliquot was
removed as an input sample. The remaining chromatin solution
was diluted 10-fold in ChIP-buffer (50 mM Tris, 150 mM NaCl,
0.25 mM EDTA, 1% Triton X-100, 0.1% sodium desoxycholate,
pH 8.1) supplemented with 1 mM phenyl-methyl-sulfonylfluoride.
The samples were precleared for 1 h at 4uC with 20 ml Pansorbin
cells (Calbiochem, Darmstadt, Germany) that had been blocked
with BSA (0.1%) and 0.4 mg/ml herring sperm DNA overnight
and washed in dialysis buffer (50 mM Tris, 2 mM EDTA, pH 8).
One third of each sample was incubated overnight with 3 mg of
antibodies against RAR, RXR or with an isotype-matched
immunoglobulin G (anti-HRS). For Egr1-ChIP, half of the sample
was incubated with 5 ml of Egr1 antibody and the other half with
5 ml of an isotype-matched immunoglobulin G (anti-EGFR).
Immunoprecipitation was performed by adding 30 ml of pre-
blocked Pansorbin cells for 2 h at 4uC. Pansorbin beads were
washed twice with ChIP-buffer and twice with PBS with
centrifugation steps (2 min, 1500 g, 4uC) in between. Elution
Figure 3. Flotillin-1 and flotillin-2 promoter activity is induced by Egr1, SRF and ERK2. Flotillin promoter constructs F1-1330 (A, C, E) or F2-
2130 (B, D, F) were cotransfected into Hela cells together with expression plasmids for Egr1, SRF, empty PSV control plasmid or with the ERK2
expression constructs, and the cells were lysed 48 h post-transfection. Relative luciferase activity of the control sample was set as 1. Values are mean
6 standard deviation of at least 4 experiments measured in duplicates. ***p,0.001; **p,0.01; *p,0.05 vs. control.
doi:10.1371/journal.pone.0045514.g003
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was done twice (15 min, room temperature) in 150 ml elution
buffer (0.1 M NaHCO3, 1% SDS). Cross-linking was reversed by
adding NaCl to a final concentration of 0.3 M and 20 mg of
RNAse A and incubation at 65uC for 4 h. Proteinase K digestion
was performed for 1 h at 55uC. Samples were purified by phenol-
chloroform extraction and ethanol precipitation. PCR was
performed with primers Flot1-375 fwd, Flot1-rev and Flot2-ChIP
fwd and rev, respectively. PCR products were separated on 1.5%
agarose gels.
Statistical analysis
Unless otherwise stated, all experiments were performed at least
three times. Data are expressed as mean 6 SD. Statistical
comparisons between groups were made using Student’s t-tests,
1way or 2way ANOVA, as appropriate (GraphPad Prism 5, San
Diego, CA, USA). Western blot bands were quantified by scanning
densitometry using Quantity One Software (Bio-Rad) and
normalized against GAPDH. Values of p,0.05 were considered
significant (*) while values of p,0.01 were considered very
significant (**) and p,0.001 extremely significant (***).
Results
The genomic regions of flotillin-1 and -2 upstream of the
ATG start codon contain an active promoter
Four human flotillin promoter fragments with a maximum
length of 2600 bp (flotillin-1) and 2130 bp (flotillin-2) were
generated by PCR and cloned into the reporter gene plasmid
pGL3-basic. All constructs displayed a relative luciferase activity
that was significantly higher than the activity of the empty control
plasmid pGL3-basic (Fig. 1). In the case of flotillin-1, the basal
promoter activity was highest for the second-longest construct F1-
1330 and very low for the shortest construct F1-375, indicating
that the region upstream of 375 bp from the ATG start codon
contains elements essential for the basal flotillin-1 promoter
activity. Flotillin-2 promoter activity was found to be highest with
the longest construct and was reduced to about 50% in the shortest
construct reaching 560 bp upstream of ATG.
The promoter regions of flotillin-1 and flotillin-2 are
conserved among species and contain a similar set of
putative transcription factor binding sites
After the identification of a functional promoter region in the
human flotillin-1 and -2 genes, genomic sequences of flotillin-1
and flotillin-2 of five different species (human, mouse, rat,
chimpanzee, and cow) were compared to identify conserved
regions and putative transcription factor binding sites, which
would imply that common transcriptional regulatory mechanisms
exist. Of each genomic sequence, 1000 bp upstream of the ATG
start codon were used for the computer-based analyses. The
analysis was done with genomic sequences of five species to reduce
the amount of false-positive matches. Sequences of mouse, rat,
chimpanzee and cow were to .51% (flotillin-1) and .57%
(flotillin-2) identical to the human sequence (Table 2). Analysis for
putative transcription factor binding sites revealed a set of 19
transcription factor families whose binding sites are present in both
flotillin-1 and flotillin-2 of all five species analyzed (Table 3). For
many of them (e.g. EGRF family), the putative responsive element
was found multiple times per sequence, making a functional role of
these transcription factors likely. In further parts of this study, we
focused on the transcription factor families EGRF, ETSF, and
RXRF, the functionality of which was analyzed in more detail.
Flotillin-1 and flotillin-2 promoters are activated by EGF
in a MAPK/ERK1/2 dependent manner and by PMA, FGF
and FCS
We recently identified flotillin-1 as a key regulator of EGF
receptor and the downstream mitogen activated protein kinase
(MAPK) ERK1/2 signaling. In this cascade, flotillin-1 forms a
molecular complex with EGFR, but also with CRAF, MEK1,
ERK1/2 and KSR1, thus putatively working as a novel MAPK
scaffolder [13]. Because of the essential role of flotillin-1 in EGF
Figure 4. Induction of endogenous flotillin expression by Egr1 and SRF. Hela cells were transiently transfected with expression constructs
for Egr1 or SRF. Empty PSV vector served as control. (A) Cell lysates were analyzed for flotillin-1 and -2 by Western blotting (left) and quantified (right).
(B) RNA was isolated, transcribed into cDNA and analyzed by qPCR. Values are means 6 standard deviation of 7 (Western Blot) or 4 (qPCR)
experiments.*p,0.05, **, p,0.01 vs. control.
doi:10.1371/journal.pone.0045514.g004
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receptor signaling, we analyzed if the expression of flotillins
themselves is regulated by growth factors such as EGF. For this,
the luciferase reporter assay with flotillin promoter constructs was
performed in EGF stimulated cells. In the case of flotillin-1,
constructs F1-2600 and F1-1330 were significantly activated by
EGF as compared to the unstimulated cells, whereas the shorter
ones showed no significant activation (Fig. 2A, left). Similarly, the
3 longest promoter constructs of flotillin-2 were significantly
activated by EGF (Fig. 2A, right). Interestingly, the three longest
flotillin-1 and all four flotillin-2 constructs displayed a basal activity
even in unstimulated cells, as compared to the cells transfected
with the control vector. To check if the EGF induced increase in
the flotillin promoter activity was due to activation of the MAPKs
ERK1/2, we used an inhibitor specific for the MAPK kinases
MEK1/2, which reside immediately upstream of ERK1/2 in the
pathway and are essential for ERK1/2 activation. Incubation of
the cells with the MEK1/2 inhibitor U0126 not only completely
abolished the stimulatory effect of EGF, but also significantly
suppressed the basal promoter activity. This indicates that already
the basal expression of flotillins is in part dependent on the
MAPKs ERK1/2. This effect was particularly strong for flotillin-1,
which itself modulates MAPK signaling. Based on the above data,
flotillins thus can be added to the list of ERK1/2 regulated genes.
To check if the flotillin promoters also respond to other growth
factors and stimuli, the above experiments were repeated with
PMA, FCS or basic Fibroblast Growth Factor (bFGF) as
stimulating agents which all result in downstream ERK1/2
activation. PMA is known to activate protein kinase C (PKC), a
Ser/Thr kinase family with a role in cell growth, proliferation and
tumorigenesis [35]. Activation of PKC leads to activation of cRaf
and, hence, to a downstream activation of ERK1/2. Stimulation
with PMA resulted in a strong activation of the three longest
flotillin-1 promoter constructs and of all four flotillin-2 promoter
constructs (Fig. 2B), very similarly to EGF. Since the second
longest flotillin-1 and longest flotillin-2 promoter construct gave
the strongest activation in the above experiments, we used these
two constructs in most of the further studies. Stimulation of the
cells with either bFGF which activates ERK1/2 and PI3K through
the FGF receptor activation (Fig. 2C) or with FCS (Fig. 2D), which
contains a mixture of growth factors, also resulted in an increased
promoter activity which was more pronounced for flotillin-1 than
for flotillin-2. In fact, a significant activation by FGF was only
observed with flotillin-1 whereas flotillin-2 activation remained just
below the significance level (p = 0.09). However, FCS-induced
activation was significant for both flotillins. In summary, the
promoters of both flotillins are activated by several stimuli that all
derive from an upstream activation of ERK1/2.
Flotillin-1 and flotillin-2 promoter activity and
endogenous flotillin expression are increased by Egr1
and SRF
Activation of the MAPK ERK1/2 leads to downstream
activation of several transcription factors that transduce the signal
into the nucleus. The identification of ERK1/2 as a regulator of
basal and growth factor induced flotillin promoter activity
prompted us to identify the transcription factors that are
responsible for the observed effects. According to the computer-
based sequence analysis, candidate transcription factors include
the early growth response gene Egr1 and transcription factors of
the ETS family, such as Elk1. Elk1 forms heterodimers with the
serum response factor SRF and binds to the serum response
element in the promoter region of its target genes. Both Egr1 and
SRF were able to significantly activate the promoters of flotillin-1
and flotillin-2 (Fig. 3A-D), confirming a role for these transcription
factors in the transcriptional control of flotillins.
To test this further, we performed cotransfection experiments to
measure the effect of ERK2 expression on flotillin promoter
activation. For this, wild-type (WT), constitutively active (CA) and
dominant negative (DN) mutant ERK2 expression constructs were
used [32]. As shown in Fig. 3E–F, expression of WT or CA but not
of DN ERK2 led to a significantly higher stimulation of flotillin
transcription in PMA stimulated cells as compared to the control
cells cotransfected with an empty expression vector.
To study if the increase in promoter activity is reflected by an
increase in mRNA and protein content, expression of endogenous
flotillins was analyzed in cells overexpressing either Egr1 or SRF,
the expression of which was confirmed by Western blot in all
experiments (data not shown). Although HeLa cells express fairly
high amounts of flotillins already at basal conditions and their
upregulation may thus be difficult to observe, overexpression of
either Egr1 or SRF resulted in a significant induction of flotillin
expression on protein level (Fig. 4A). RNA levels (Fig. 4B) showed
the same tendency but did not reach statistical significance (except
for SRF in flotillin-1 regulation) due to high variations between the
experiments.
Figure 5. Flotillin-1 and flotillin-2 promoter activity is induced
by trans-retinoic acid. Flotillin promoter fragments of different
length in pGL3-basic were transiently transfected into Hela cells. One
day post-transfection, the cells were stimulated with trans-RA (1 mM) for
24 h in serum-free medium. Relative luciferase activity of the
unstimulated longest promoter construct was set as 1. (A) flotillin-1,
(B) flotillin-2. Values are means 6 standard deviation of at least 3
experiments measured in duplicates. ***p,0.001; **p,0.01; *p,0.05
vs. unstimulated sample.
doi:10.1371/journal.pone.0045514.g005
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Flotillin-1 and flotillin-2 promoter activity and
endogenous flotillin expression are increased by retinoic
acid, RXRa, RARa, and PPARc
The computer-based analysis of the two flotillin promoters
revealed 19 conserved putative transcription factor binding sites.
Of particular interest was the presence of multiple retinoid X
receptor (RXR) heterodimer binding sites in both promoters. The
RXR is activated by retinoic acid, a compound that has already
been described to affect the expression of flotillins [36]. Therefore,
reporter gene assays with flotillin promoter constructs were
performed in the presence of trans-retinoic acid. As shown in
Fig. 5, retinoic acid is a strong activator of both flotillin promoters.
RXR is the dimerization partner of several nuclear receptors,
including retinoic acid receptors (RAR) and peroxisome prolif-
erator activated receptors (PPAR). Therefore, we next tested the
effect of overexpressed RXRa, RARa, and PPARc on the activity
of flotillin promoters. Overexpression of RARa and RXRa alone
or together resulted in an increased promoter activity, which was
even more enhanced in the presence of retinoic acid (Fig. 6A, B).
Figure 6. Flotillin promoter activity is induced by RXR, RAR, PPARc, and the PPARc activator troglitazone. Flotillin promoter constructs
F1-1330 (A, C) or F2-2130 (B, D) were cotransfected into Hela cells together with expression plasmids for RAR, RXR, PPARc or with empty PSV control
plasmid. One day post-transfection, the cells were stimulated with trans-RA (1 mM) for 24 h in serum-free medium. Relative luciferase activity of the
unstimulated control sample was set as 1. F1-1330 (E) and F2-2130 (F) transfected Hela cells were stimulated with troglitazone for 24 h in serum-free
medium. Values are mean 6 standard deviation of at least 3 experiments measured in duplicates. ***p,0.001; **p,0.01; *p,0.05 vs. respective
control.
doi:10.1371/journal.pone.0045514.g006
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In particular, RARa exhibited a strong effect on flotillin-2
promoter activity even in unstimulated cells (Fig. 6B). Similarly,
PPARc overexpression led to an increased promoter activity of
flotillin-1 (Fig. 6C). In the case of flotillin-2, PPARc was
significantly effective only in the presence of its binding partner
RXR (Fig. 6D). PPARc, similarly to RAR and RXR, is a ligand-
activated transcription factor, with the antidiabetic drug trogli-
tazone being a typical PPARc ligand. In line with the
overexpression data, stimulation with increasing amounts of
troglitazone resulted in a dose-dependent activation of both
flotillin promoters even in the absence of PPARc overexpression
(Fig 6E, F).
To see if the above effects on promoter activity also result in an
increased expression of endogenous flotillins, flotillin protein and
mRNA expression were analyzed with Western blot and qPCR
in retinoic acid stimulated cells overexpressing RARa, RXRa or
PPARc. In line with the promoter data, stimulation with
retinoic acid led to an increase in flotillin protein expression,
especially in RXRa transfected cells (Fig. 7 A–C, densitometric
quantification in 7D–E). In addition, overexpression of either
RARa or PPARc resulted in an increased flotillin expression on
mRNA level (Fig. 7F). In summary, both flotillin-1 and flotillin-2
contain functional binding sites for RXR and its binding
partners and, hence, can be classified as retinoic acid responsive
genes.
Figure 7. Induction of endogenous flotillin expression by RAR, RXR, retinoic acid, and PPARc. Hela cells were transiently transfected with
expression constructs for RAR, RXR, or a combination of both. Empty PSV vector served as a control. One day post-transfection, the cells were
stimulated with trans-RA (1 mM) in serum-free medium for 24 h. Cell lysates were analyzed for flotillin-1 (A), flotillin-2 (B), RAR and RXR (C) by Western
blotting. D and E show a densitometric quantification of flotillin expression. F: Cells were transfected with RAR or PPARc expression construct or
empty PSV. RNA was isolated, transcribed into cDNA and flotillin mRNA was measured by qPCR. Values are mean 6 standard deviation of at least 3
experiments. ###, p,0.001; #, p,0.05; vs control *, p,0.05 vs. unstimulated sample.
doi:10.1371/journal.pone.0045514.g007
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RXRa, RARa, and Egr1 bind to the promoter of flotillin-1
and -2
To directly show that the transcription factors RARa, RXRa
and Egr1 bind to flotillin promoters, we performed chromatin IP
(ChIP) assays with antibodies specific for RARa, RXRa and Egr1,
and isotype-matched control antibodies. PCR primers amplifying
approximately 400 bp of the genomic region of flotillin-1 and
flotillin-2 upstream of the ATG start codon were used for the
detection of the precipitated DNA fragment (Fig. 8). RXRa and
Egr1 were found to bind to promoters of both flotillins, whereas
RAR only bound to flotillin-2 promoter, consistent with the
overexpression data shown in Fig. 6B.
The transcriptional regulation of flotillins is conserved
among species
All experiments shown so far were performed with the human
flotillin promoter constructs. According to the computer-based
sequence analysis (Table 3), all transcription factors that were
identified in the present study should be able to activate the flotillin
promoters of the other four species. In order to confirm this
hypothesis, approximately 1000 bp of the murine flotillin-1 and -2
promoters were cloned into pGL3-basic and used for reporter
gene analysis. Similar to the results obtained with the human
constructs, stimulation with EGF, retinoic acid, PMA, or
troglitazone resulted in an increased activity of the murine
promoter constructs (Fig. 9A and B). Furthermore, both murine
promoters were directly activated by the transcription factors
RARa, RXRa (Fig. 9C and D), Egr1 (Fig. 9E and F) and SRF
(Fig. 9G and H), confirming a species-conserved transcriptional
regulation of flotillins by these transcription factors.
Mutations of the binding sites for the RXR family or Egr1
impair flotillin-2 transcription
Our data above suggested that the RXR and EGRF transcrip-
tion factor families are involved in the regulation of flotillin
transcription. To show that the identified binding sites for these
factors in the flotillin promoters are required for the transcriptional
activation, we performed site-directed mutagenesis. Since the
number of the binding sites in human flotillin promoters is too
high to be feasible for these studies (see Table 3), we mutated the
sites in the mouse flotillin-2 proximal promoter construct which
contains 2 sites for Egr1 and 3 sites for the RXR family (Fig. 10A).
Figure 8. RXR, RAR, and Egr1 bind to the promoter of flotillin-1
and flotillin-2. Chromatin immunoprecipitations were carried out in
Hela cells as described in Materials and Methods. DNA/protein
complexes were precipitated with antibodies against RXR, RAR, Egr1
or HRS (IgG control). Coprecipitated DNA fragments were amplified
with primers specific for approximately 500 bp (flotillin-1) (A) or 400 bp
(flotillin-2) (B) of genomic DNA directly upstream of the ATG start
codon. Results are representative of two independent experiments.
doi:10.1371/journal.pone.0045514.g008
Figure 9. Murine flotillin promoters are activated in a similar manner as the human promoters. Murine flotillin-1 (A, C, E, G) or flotillin-2
(B, D, F, H) promoter constructs were transiently transfected into Hela cells, either alone or in combination with the expression constructs for
transcription factors. One day post-transfection, the cells in A–D were stimulated with EGF (10 ng/ml), trans-RA (1 mM), PMA (10 ng/ml), or
troglitazone (10 mM) in serum-free medium for 24 h. Cells in E–H were lysed 48 h post-transfection. Values are means6 standard deviation of at least
3 experiments measured in duplicates. ***, p,0.001; **, p,0.01; *, p,0.05 vs. control.
doi:10.1371/journal.pone.0045514.g009
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The RXR binding sites were individually mutated using extension
overlap PCR [31], whereas the Egr1 binding sites which are
located close to each other and to the 39 end of the promoter
sequence were deleted. We also produced constructs in which
individual RXR site mutations were combined with a 39 deletion.
As shown in Fig. 10B, deletion of the Egr1 binding sites severely
impaired PMA-mediated transcriptional activation, although it did
not completely prevent it. Single mutation of the RXR family
binding sites did not abrogate the transcriptional activation of the
reporter constructs upon RA stimulation (Data not shown).
However, when the mutations of the RXR binding sites 2 and 3
were combined with a deletion in the 39 region removing the Egr1
binding sites, the transcriptional activation induced by retinoic
acid was completely abolished (Fig. 10C). This seems not to be due
to the absence of the 39 region as such, since the Erg1 site deletion
construct exhibited a significant albeit reduced transcriptional
activation and lower basal activity. Interestingly, the basal activity
of the RXR site mutant constructs was also drastically reduced
(Fig. 10C). In summary, our data show that RXR and Egr1
families are involved in the transcriptional regulation of flotillins
across the species.
Discussion
In general, control of transcription determines whether or not a
gene is expressed and also how much of it is expressed under
certain conditions. Until now, the transcriptional regulation of
flotillin expression is only poorly understood, despite their
important functions in various signaling pathways and their
altered expression in cancer and neurodegenerative diseases. In
this study, we have performed an analysis of the transcriptional
regulation of human and mouse flotillins, with focus on the
proximal promoter regions of the respective genes. Although we
here show that these regions contain important regulatory
sequences that control flotillin expression, it is possible that the
genomic sequences further upstream or the intron of flotillins
contain additional cis regulatory elements that were not identified
by our study.
Here we show that flotillin-1 and flotillin-2 are direct
transcriptional targets of 1) growth factor-induced MAPK-
signaling, mediated by Egr1 and SRF, and 2) nuclear receptors
that dimerize with RXR. Importantly, we also demonstrate that
this regulation is conserved among species. In the light of our
recent findings that flotillin-1 is an important regulator of MAPK
signaling [13], the finding that flotillin expression is controlled by
MAPKs, most likely through Egr1 and SRF activation, is
especially intriguing. The MAPK pathway plays a central role in
a variety of signaling networks and mediates many of the
intracellular actions of e.g. growth factors. It is widely accepted
that aberrant signaling can lead to malignant transformation of
cells and to carcinogenesis, as has been shown e.g. for
overexpressed EGFR [37]. The MAPK family members extracel-
lularly regulated kinases ERK1 and ERK2 represent targets at
Figure 10. Mutagenesis of Egr1 or RXR binding sites prevents transcriptional activation of mouse flotillin-2. A: mouse flotillin-2
proximal promoter sequence. The three putative binding sites for the RXR family and the two sites for Egr1 are shown in bold and underlined. The
sequence shown in italics was deleted to remove the Egr1 binding sites. Mouse flotillin-2 promoter activity after PMA stimulation (B) or retinoic acid
stimulation (C). Transfection and stimulation were performed as in Figure 9.
doi:10.1371/journal.pone.0045514.g010
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which signals from different growth factor receptors converge. In
quiescent cells, ERK1/2 are mainly located in the cytoplasm
where they are bound to MEK1/2. The nuclear export signal of
MEK1/2 prevents the nuclear translocation of ERK1/2 [38].
Phosphorylation of ERK1/2 by MEK1/2 is necessary for the
dissociation of the MEK/ERK complex. Since our recent data
show that flotillin-1 is a novel MAPK scaffolder that is essential for
full ERK activation and directly interacts with both MEK1 and
ERK2 [13], it may also regulate the localization of the MEK/
ERK complex. Thus, transcriptional regulation of flotillins by
MAPK pathway might provide a feedback loop that affects the
activation status and duration of MAPK signaling.
Activated ERK1/2 dimerize and translocate to the nucleus
where they bind to and phosphorylate transcription factors such as
Elk-1 [39–41], c-Myc [42], and c-Fos [43], which then induce the
transcription of several target genes. Elk-1 is one of the best-
studied ERK1/2-activated transcription factors and belongs to the
group of Ets ternary complex factors (overview in [44]). Direct
phosphorylation of Elk-1 at the C-terminus by ERK1/2 occurs
rapidly at six sites [45]. In addition, a MAPK-independent
phosphorylation of Elk-1 in response to FGF stimulation or Raf
activation has been described [46]. Elk-1 forms a complex with
serum response factor (SRF) and binds to the serum response
element (SRE) in promoters of several immediate early genes such
as c-Fos [47] or Egr1 [48]. SRF is essential for the activation
through the SRE, since mutations that abolish the SRF-binding
inhibit the activation of gene expression [49]. The SRF gene itself
is induced in response to serum stimulation [50].
ERK1/2 are important contributors to cell proliferation, since
common downstream targets of the three ERK1/2 substrates c-
Fos, Elk-1, and c-Myc are genes that regulate cell cycle
progression, such as cyclin D1 (summarized in [51]). In line with
this, we recently found that flotillins are needed for cyclin D1
expression, since a knockdown of flotillin-1 in HeLa cells resulted
in a reduced basal as well as EGF-induced cyclin D1 expression
[13] and also in an arrest of the cell cycle in G1 (our unpublished
observations), indicating that flotillins are needed for a sustained
signaling downstream of ERK1/2. In general, activation of the
Raf/MEK/ERK cascade is associated with increased prolifera-
tion, and a dysregulation thereof is a hallmark of many tumors. In
fact, activating mutations of upstream components of ERK1/2 are
responsible for many human cancers, as summarized in [52].
Other typical ERK1/2 downstream target genes are ‘‘early
response genes’’ such as the transcription factor c-Fos and the
early growth response gene Egr1. The promoter region of these
genes contains at least one serum response element SRE (see
above). Egr1, originally described as NGFI-A [53], is a zinc-finger
transcription factor whose expression is low in resting cells, but is
rapidly induced upon EGFR activation [54] in an ERK1/2-
dependent manner [55] and after treatment with PMA, EGF or
serum [56]. In this study, we show that all these stimuli also result
in flotillin promoter activation, further pointing to ERK1/2 and
Egr1 as important regulators of flotillin expression.
The Egr1 promoter contains five SREs [48] that are bound by
Elk-1/SRF dimers. Accordingly, overexpression of SRF in HeLa
cells results in an increased expression of Egr1 (our unpublished
data). Egr1 controls the expression of a large number of target
genes, most of which are related to cell growth and apoptosis, such
as p53, TGFß1 and PTEN [57–59]. In addition, Egr1 downreg-
ulates its own expression [60], resulting in termination of Egr1-
regulated gene expression, thus making sure that the signaling is
only transient. The potential role of Egr1 in cancer is not fully
understood, since Egr1 has been shown to either promote [61] or
suppress cell proliferation and/or cancer progression in a cell and
tissue specific manner (overview in [62]). Here we show that Egr1
overexpression results in transcriptional activation of flotillins and
increase in the cellular flotillin protein amount, suggesting that
flotillins are Egr1-regulated genes. Furthermore, removal of the
Egr1 binding sites severely impairs the PMA induced transcrip-
tional activation of the mouse flotillin-2 gene. Further evidence for
this comes from microarray analysis of Egr1 knockout MEFs in
which the expression of flotillin-1 mRNA was found to be
decreased [59]. This finding was not studied further by the
authors, but it is well supported by our data presented here.
The regulation of flotillin expression by Egr1 and SRF, both of
which have multiple binding sites within the human flotillin
promoters and are activated or induced upon ERK1/2 activation,
may seem at the first glance somewhat redundant, with Egr1 being
under transcriptional control of SRF. However, flotillins are not
the only genes under direct control of both SRF and Egr1.
Transcription of the ubiquitin carrier protein (UCP) was also
shown to be directly controlled by SRF and Egr1 and to be
upregulated upon treatment of HeLa cells with EGF, HGF, PMA,
or serum [56], similarly to flotillins. Therefore, Egr1 and SRF can
induce gene expression independently of each other as well as in
collaboration.
The in-silico analysis of the mammalian genomic flotillin-1 and -
2 sequences revealed 19 different, species-conserved putative
transcription factor families, whose complete functional analysis is
beyond the scope of this publication. To confirm the reliability of
our computer-based analysis, another transcription factor family
whose influence on the regulation of flotillin expression appeared
interesting was analyzed. Independent from the regulation of
flotillins by Egr1 and SRF, flotillin promoter activity and
endogenous flotillin expression were increased by the vitamin A
derivative all-trans retinoic acid, which regulates gene expression
by acting as a ligand for the nuclear receptors RAR (all-trans
retinoic acid) and RXR (the all-trans retinoic acid metabolite 9-cis
retinoic acid). Mutations of the the individual binding sites for the
RXR family factors in the mouse flotillin-2 promoter did not result
in reduced activation, whereas a combination with a 39 deletion
removing the Egr1 binding sites completely abrogated the RA
induced transcriptional response. However, since the removal of
the 39 region containing the Erg1 binding sites alone did not cause
an impairment of RA induced activation, the identified RXR
binding sites appear to be important for the transcriptional
regulation, together with the 39 region.
Retinoic acid exerts versatile cellular effects and regulates cell
differentiation and cell growth and acts as a morphogen during
embryogenesis (for review, see [63]). Furthermore, retinoic acid
causes a MEK1/2 dependent phosphorylation of ERK2 and
activation of Elk-1 in HL-60 myeloblastic leukemia cells [64],
linking retinoid metabolism to MAPK signaling. Another link is
provided by the fact that EGF stimulates the expression of retinoic
acid receptor RARa [65].
The retinoid X receptor RXR serves as an obligatory binding
partner for several members of the nuclear receptor superfamily
including LXR, PPAR, and RAR (reviewed in [66,67]). Due to its
role as a heterodimerization partner, RXR is able to control the
function of many nuclear receptors. The peroxisome proliferator
activated receptors, PPARs, are activated by various lipids, and
long-chain fatty acids most likely are their natural ligands [68].
PPARc plays a critical role in adipogenesis and fat storage [69] but
also in glucose metabolism and thus in energy regulation. Nuclear
receptors are of great interest for drug development and some such
as PPARc are already successfully targeted by antidiabetic drugs
[70]. The upregulation of flotillin expression upon retinoic acid
treatment or forced expression of RAR, RXR or PPAR suggests a
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role for flotillins in embryogenesis, cell differentiation as well as
lipid and glucose metabolism. Experimental proof for the function
of flotillins in all these processes already exists. The expression of
flotillins depends on the differentiation status of a cell and increases
during the differentiation process of osteoclasts [71], skeletal
myoblasts [72], and 3T3 fibroblasts [1]. In drosophila, flotillins are
most abundantly expressed in the embryonic nervous system [73],
suggesting a morphogenic function. The drosophila flotillin-2 gene
appears to be under the control of the transcription factors of Grh,
AP-1 and ETS families [30]. Overexpression of flotillin-2 in
drosophila leads to abnormal morphogen distribution, impaired
wing development, mislocalization of adhesion molecules, as well
as to abnormalities in eyes, ocelli and bristles [74,75]. However,
flotillin-2 overexpressing flies are viable and fertile, but show a
defect in the control of transcriptional response after embryonic
wounding, implicating that flotillin-2 is important for the
restriction of the transcriptional response in the vicinity of the
wound [30]. In goldfish [2] and zebrafish [76,77], flotillins are
involved in axonal regeneration after injury of the optic nerve and
were originally discovered due to upregulation of their expression
after a lesion of the goldfish optic nerve [2]. In mammals, they
contribute to neurite branching and synapse formation in cultured
cells [78,79]. However, flotillin-1 [80] and flotillin-2 (our
unpublished results) knockout mice are viable, fertile, and
morphologically normal. Thus, some of the phenotypes observed
after flotillin depletion or overexpression in cultured cells may not
directly reflect the essential nature of flotillins in multicellular
organisms. On the other hand, flotillins are extremely well
conserved between species that are not closely related, suggesting
that they are in some subtle manner important for these
organisms. In our flotillin-2 knockout mice, we have observed
changes in the transcription and expression of many proteins that
regulate cell proliferation, adhesion and signaling (AB and RT,
unpublished data). Thus, it is also possible that the loss of function
of flotillins is compensated by an increased expression of e.g.
signaling proteins to overcome the defects, and no obvious
phenotype is observed, different from cell culture systems.
Therefore, is it is likely that the true molecular functions of
flotillins still remain to be discovered, and these findings stress the
importance of animal models for the verification of the functional
studies in cultured cells.
In summary, we have here characterized the expression of
flotillins at the level of transcription and were able to identify
flotillins as transcriptional targets of MAPK signaling, mediated by
the transcription factors Egr1 and SRF. Furthermore, retinoic
acid, RXRa, RARa and PPARc exert positive effects on the
expression of flotillins. These finding are of major importance for
understanding the function of flotillins in many vital processes of
the cells, such as differentiation, hormone and growth factor
signaling, regulation of cell proliferation and carcinogenesis. Our
results here thus shed important light on the characterization of
flotillin function not only at protein but also at the transcriptional
level.
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